Autoimmune Hemolytic Anemia in Children: Clinical Profile and Outcome

ObjectiveTo discover the common triggers for AIHA in children, their clinical profile, treatment response, and outcome.MethodsThis was an ambispective descriptive study conducted between 2013 and 2020. Children aged 1 mo to 14 y with hemolytic anemia and a positive direct antiglobulin test (DAT) were included. Children with a positive DAT but without any clinicolaboratory evidence of hemolysis were excluded. Data were collected from a structured pro forma with particulars comprising clinicolaboratory profile, treatment administered, and disease outcome.ResultsA total of 46 children (aged between 1 mo and 14 y) were enrolled in the study. The mean age of onset was 8.7 (+/- 4.34) y, and 24 (52.8%) were males. Secondary causes were observed in 29 (63%) cases, while the primary cause was found in 17 (37%). Systemic lupus erythematosus (SLE) was the common trigger in 13 (45%) cases, followed by malignancy in 4 (14%) cases. Pallor (98%), hepatomegaly (72%), and splenomegaly (48%) were the most commonly observed clinical signs. The mixed immunophenotype was observed in 27 (59%) cases, followed by warm type in 12 (26%) and cold agglutinin type in 7 (15%) cases. All children received glucocorticoid therapy, and mycophenolate mofetil was commonly used as second-line therapy in 15 (33%) cases. 13 cases (71%) of primary AIHA and only 4 (14%) cases of secondary anemia achieved complete remission. Overall, 7 children (15%) died, all belonging to secondary AIHA.ConclusionSecondary AIHA was more common than primary in the present study, and SLE was the standard trigger. Primary AIHA carries a better prognosis than secondary.

Automated summary

This study aimed to investigate the triggers, clinical profile, treatment response, and outcome of autoimmune hemolytic anemia (AIHA) in children. A total of 46 children aged 1 month to 14 years were included in the study. Secondary AIHA was more common than primary AIHA, with systemic lupus erythematosus (SLE) being the most common trigger. Primary AIHA had a better prognosis.